Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

McGill University

$17,500.00

Aryl Hydrocarbon Receptor Activation by Cannabinoids Protects Against Lung Inflammation

FY 2020-21

Summary
The Canadian Government fully legalized cannabis in 2018. Cannabis consumption is primarily through inhalation of cannabis smoke which allows cannabinoids and other smoke components to enter the body through the lungs. Despite legalization there is much uncertainty regarding the short- and long-term impacts of cannabis. Tetrahydrocannabinol (THC) and cannabidiol (CBD) are the most well-known cannabinoids found in cannabis. Aside from psychoactive effects, THC has been shown to decrease airway inflammation in mice. CBD is the most abundant non-psychoactive cannabinoid found in cannabis and also possesses anti-inflammatory properties. Vaporization, which heats the dried plant without igniting it, may be a therapeutic means to deliver cannabinoids in the absence of the carcinogens found in smoke. Cannabinoids are known to bind to cannabinoid receptors CB1 and CB2 as well as the GPCR55. However, our data show that there is little expression of these receptors in lung epithelial cells. Cannabinoids may exert their beneficial properties via the aryl hydrocarbon receptor (AhR), which is always expressed in lung epithelial and endothelial cells. As THC and CBD increase AhR activity, the objectives of my research are to determine the effects of these select cannabinoids as well as cannabis smoke on AhR function, and to furthermore assess the capacity of cannabinoids in attenuating the lung inflammation. I hypothesize that AhR activation by cannabinoids protects against lung inflammation associated with the damage in chronic lung diseases. This project will determine the therapeutic potential of cannabis in maintaining respiratory health by providing an improved understanding of the effects of cannabis on inflammation.
Program
Master's Award: Canada Graduate Scholarships
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
449615
Name
Wilson Emily T
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Aryl Hydrocarbon Receptor Activation by Cannabinoids Protects Against Lung Inflammation
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Aryl Hydrocarbon Receptor; Cannabinoids; Cannabis; Cbd; Fibroblast; Inflammation; Lungs; Smoke; Thc; Toxicology
Abstract
The Canadian Government fully legalized cannabis in 2018. Cannabis consumption is primarily through inhalation of cannabis smoke which allows cannabinoids and other smoke components to enter the body through the lungs. Despite legalization there is much uncertainty regarding the short- and long-term impacts of cannabis. Tetrahydrocannabinol (THC) and cannabidiol (CBD) are the most well-known cannabinoids found in cannabis. Aside from psychoactive effects, THC has been shown to decrease airway inflammation in mice. CBD is the most abundant non-psychoactive cannabinoid found in cannabis and also possesses anti-inflammatory properties. Vaporization, which heats the dried plant without igniting it, may be a therapeutic means to deliver cannabinoids in the absence of the carcinogens found in smoke. Cannabinoids are known to bind to cannabinoid receptors CB1 and CB2 as well as the GPCR55. However, our data show that there is little expression of these receptors in lung epithelial cells. Cannabinoids may exert their beneficial properties via the aryl hydrocarbon receptor (AhR), which is always expressed in lung epithelial and endothelial cells. As THC and CBD increase AhR activity, the objectives of my research are to determine the effects of these select cannabinoids as well as cannabis smoke on AhR function, and to furthermore assess the capacity of cannabinoids in attenuating the lung inflammation. I hypothesize that AhR activation by cannabinoids protects against lung inflammation associated with the damage in chronic lung diseases. This project will determine the therapeutic potential of cannabis in maintaining respiratory health by providing an improved understanding of the effects of cannabis on inflammation.
Competitiondate
202012
Approvedterm2
1 yr 0 mth
Pinamesdelim
Wilson, Emily T
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~